Key points:
- Potential Revenue Increase: The proposed tax could raise the price of nicotine pouches from $6 to $11, potentially generating up to $132 million by 2029.
- Public Health Concerns: Supporters argue that higher taxes may reduce nicotine use among minors.
- Risk of Illicit Trade: Critics caution that increased taxation could lead to a surge in black market activity, as seen in other regions with high tobacco taxes.
Washington state legislators are considering House Bill 2033, introduced by Representative Monica Stonier, aiming to broaden the definition of tobacco products to encompass all nicotine-containing items, including synthetic nicotine and pouch products. Lawmakers say the legislative move seeks to close existing tax loopholes and potentially increase state revenue.
However, industry experts say imposing higher taxes on nicotine products may lead to unintended consequences. Historical data suggests that excessive taxation on less risky nicotine delivery systems can drive consumers toward illicit markets.
For example, Australia’s aggressive tobacco tax policies have inadvertently fueled a black market, benefiting organized crime and undermining public health objectives, according to media reports.
Moreover, research indicates that steep taxes on reduced-risk nicotine products, like e-cigarettes and nicotine pouches, can deter smokers from transitioning away from combustible cigarettes.
A study published in PubMed Central found that restricting access to e-cigarettes through excessive taxation may push consumers back toward traditional cigarette consumption, either through legal reduced-nicotine or illicit normal-nicotine markets.
Doug Ball, a Washington state-based convenience store owner, argued that raising the price of nicotine pouches could push users back to more harmful products like cigarettes. “We’re talking about over $1,400 a year in taxes that could cause people to switch back to more harmful products,” Ball said.
While the FDA approved Zyn products in January, classifying them as a less risky alternative to cigarettes, they are not FDA authorized for use to quit smoking. Currently, the FDA only recommends nicotine gum, lozenges and patches for smoking cessation.
